Skip to content

Research on Intelligent Auxiliary Diagnosis and Precision Prevention of Adolescent Depressive Disorders Based on Multimodal Fusion

Research on Intelligent Auxiliary Diagnosis and Precision Prevention of Adolescent Depressive Disorders Based on Multimodal Fusion

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500096556
Enrollment
Unknown
Registered
2025-01-26
Start date
2025-02-20
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lack of concentration, excessive guilt or low self-worth, feeling hopeless about the future, thoughts of death or suicide, sleep disturbances, changes in appetite or weight, feeling extremely tired or lacking energy.

Interventions

Gold Standard:Diagnostic and statistical manual of mental disorders fifth edition, DSM-5
Index test:Collect multimodal sensing data such as text (scale), audio, and video. The Montgomery Scale was used to assess the severity of depression, and the Columbia Suicide Severity Rating Scale (C

Sponsors

Huzhou Third Municipal Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 19 Years

Inclusion criteria

Inclusion criteria: 1.Queue 1: (1) Outpatient patients at our hospital, aged 10-19 years old, who meet the diagnostic criteria for adolescent depression in DSM-5; (2) HAMD-17>7 points, CGI-S >= 3 points, Young Mania Rating Scale, YMRS>= 6, Right handed; (3) Sign informed consent form; 2.Queue 2: (1) High school students and young people seeking help from the psychological hotline in this city; (2) Age: 10-19 years old. (3) Sign the informed consent form.

Exclusion criteria

Exclusion criteria: a. History of loss of consciousness due to organic brain disease or head trauma; b. Any significant or unstable cardiovascular, respiratory, neurological (including epilepsy or significant cerebrovascular disease, head injury), renal, hepatic, endocrine or immunological or organic disease causing anxiety, History of depression or current infection, trauma, etc.; c. Arbitrary contraindication to MRI, or structural abnormalities of the brain found on magnetic resonance examination; d. Have hearing problems (inability to hear or understand the examiner's speech under normal conversation); e. Psychoactive substance abuse and dependence History; f. Long-term use of anticholinergic drugs. g. Those who have serious suicidal ideation and behavior; h. Antidepressant or ECT therapy or rTMS therapy within six months.

Design outcomes

Primary

MeasureTime frame
Based on scale evaluation;Accuracy;Sensitivity;Specificity;

Secondary

MeasureTime frame
Based on speech intonation;Positive predicative value;Negative predictive value;

Countries

China

Contacts

Public Contactwang shiliang

Huzhou Third Municipal Hospital

93889766@qq.com+86 572 212 9892

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026